Journal
CURRENT HYPERTENSION REPORTS
Volume 18, Issue 7, Pages -Publisher
SPRINGER
DOI: 10.1007/s11906-016-0664-3
Keywords
Preeclampsia; Hypertension; Placental disease; Pregnancy complications; Aspirin; Heparin
Categories
Funding
- Hellenic Society of Hematology
Ask authors/readers for more resources
Preeclampsia is a hypertensive disorder of pregnancy that remains a significant cause of maternal morbidity and mortality worldwide. Preeclampsia can be resolved by delivery, and most of the proposed preventive treatment approaches are based on processes involved in placental development in early pregnancy. Yet, none of these has been established in clinical practice. Low-dose aspirin is the most promising candidate, nevertheless; while some individual randomized controlled trials showed minimal or no statistically significant benefit, recent metanalyses showed that early initiation before 16 weeks of gestation is associated with prevention of early-onset preeclampsia and reduction in prevalence of perinatal death or morbidity of pregnant women. Heparin could be an alternative antithrombotic and anti-inflammatory median to prevent preeclampsia either alone or in combination with aspirin; however, results are conflicting concerning efficacy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available